Brief: T2 Biosystems Advances To The Phase 2 In HHS And The Steven And Alexandra Cohen Foundation’S Lymex Diagnostics Prize
06/02/2023 21:14
Feb 6 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS ADVANCES TO THE PHASE 2 IN HHS AND THE
STEVEN AND
ALEXANDRA COHEN FOUNDATION’S LYMEX DIAGNOSTICS PRIZE
Source text for Eikon: ID:nGNX12gY9z
Further company coverage: TTOO.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor